ChemicalBook > CAS DataBase List > Bulleyaconitine A
Bulleyaconitine A
Bulleyaconitine A
- CAS No.107668-79-1
- Chemical Name:Bulleyaconitine A
- CBNumber:CB9291737
- Molecular Formula:C35H49NO9
- Formula Weight:627.76
- MOL File:107668-79-1.mol
Bulleyaconitine A Property
- Boiling point 690.9±55.0 °C(Predicted)
- Density 1.28±0.1 g/cm3(Predicted)
- storage temp. Store at 2-8°C
- solubility DMSO: 125 mg/mL (199.12 mM)
- form Solid
- pka 13.12±0.70(Predicted)
- color White to off-white
- FDA UNII 7VFN6Z3BRE
-
Symbol(GHS)
- Signal wordDanger
- Hazard statements H330-H300
- Precautionary statements P260-P271-P284-P304+P340-P310-P320-P403+P233-P405-P501-P264-P270-P301+P310-P321-P330-P405-P501
Bulleyaconitine A Chemical Properties,Usage,Production
- Description Bulleyaconitine A is an aconitine-type two terpene alkaloid, and its molecular formula is C35H49NO10.?As early as 1980, bulleyaconitine was separated and extracted from a traditional analgesic and anti-inflammatory herb in the west of Yunnan called dianxi dula (or dianxi wutou) (Aconitum bulleyanum Diels), by the Kunming Institute of Botany, Chinese Academy of Sciences . At present, bulleyaconitine A can be separated from Aconitum plants, for example, dianxi wutou (Aconitum bulleyanum Diels), cujing wutou (Aconitum crassicaule W.T.?Wang), changhui wutou (Aconitum georgei Comber), and zhiyuan wutou (Aconitum transsectum Diels).
- Physical properties Appearance: white powder. Solubility: soluble in methanol, ethanol, chloroform, and ether; insoluble in water; and easily dissolved in dilute hydrochloric acid or dilute sulfuric acid . Melting point: 160–165?°C
- History In 1983, it was confirmed that bulleyaconitine A shows obvious analgesic and antiinflammatory effects by preclinical pharmacological tests . Clinical trials were carried out in 29 hospitals in 9 provinces in 1984. Bulleyaconitine A passed technical appraisals in May 1985 and was first formally put into production by Yunnan Honghe Pingbian pharmaceutical company, where it obtained the trade name “Bulleyaconitine A.” Bulleyaconitine A has been listed into the Pharmacopoeia of the People’s Republic of China (2015). In recent years, bulleyaconitine A has shown a great market growth and competitive power, owing to its exact curative effect and rapid clinical promotion in chronic disease and rheumatic immune disease.
- Uses Bulleyaconitine A is an agent that expresses long-lasting local anaesthetic properties used in the treatment of chronic pain and arthritis. Commonly used in China as a traditional medicine.
-
Pharmacology
1. Anti-inflammatory and analgesic effect. Bulleyaconitine A plays a significant
anti-inflammatory effect by inhibiting the release of prostaglandins. The analgesic effect may be related to the rivalry of 5-HT and the inhibition of inflammatory
chemokines in the brain, because inhibition of PGE2 release may lead to disinhibition of β-endorphin . Further studies showed that bulleyaconitine A achieved
the analgesic effect by effectively reducing sodium ion current, the electrophysiological basis on which pain conduction is dependent . Zhanguo Niu et?al.
found that bulleyaconitine A could be used to treat mild and moderate burn pain,
with less adverse reactions and no addiction . Thus, bulleyaconitine A may be
suitable for long-term use as a choice of analgesic therapy for burn pain. Recently,
through clinical observation on the effect of bulleyaconitine A treatment in acute
gouty arthritis, some scholars discovered that bulleyaconitine A brought about
good effect and could effectively improve the clinical symptoms of patients by
taking 0.4?mg bulleyaconitine A orally three times in daily .
2. Immune regulation. Bulleyaconitine A has obvious inhibitory effects to immune cells involved in joint inflammation, which may have a close relationship to its clinical anti-inflammatory effect. Ye Lu et?al. studied the influence of bulleyaconitine A on partial immune functions of BALB/c mice and found that 0.32?mg/kg bulleyaconitine A inhibits some immune functions of BALB/c mice . Moreover, it was reported that bulleyaconitine A significantly inhibited the phagocytic function and the ability to secrete nitric oxide (NO) of macrophages .
3. Other pharmacological effects. An injection of 0.1 mg/kg bulleyaconitin A in fasting rat can inhibit the formation of corneal neovascularization induced by alkali burn . Bulleyaconitine A also has local anesthesia and antipyretic effect. Besides, bulleyaconitine A can be used for the treatment of lumbar muscle strain, scapulohumeral periarthritis, and sprain of limbs. -
Clinical Use
1. Rheumatic immune disease. Since listing, bulleyaconitine A has been applied in
clinical treatment for rheumatoid arthritis and osteoarthritis, receiving good
curative effects.
2. Chronic pain. Bulleyaconitine A does not belong to NSAID, and it exerts its effects by regulating the sodium ion channel. So there is little psychological dependence and organ toxicity, avoiding gastrointestinal/cardiovascular/renal adverse reactions and drug dependence or other potential dangers caused by NSAID and opioid analgesics.
Bulleyaconitine A Preparation Products And Raw materials
Raw materials
Preparation Products
Global(205)Suppliers
-
Supplier:
- Tel:18017610038
- Email:zheyansh@163.com
- Country:CHINA
- ProdList:3619
- Advantage:58
-
Supplier:
- Tel:+86-0371-86658258<br/>+8613203830695
- Email:sales@coreychem.com
- Country:China
- ProdList:29858
- Advantage:58
-
Supplier:
- Tel:+86-28-82633860;<br/>+8618080483897
- Email:sales@biopurify.com
- Country:China
- ProdList:3772
- Advantage:58
-
Supplier:
- Tel:18905173768
- Email:sales@dolonchem.com
- Country:CHINA
- ProdList:2972
- Advantage:58
-
Supplier:
- Tel:18871490254
- Email:linda@hubeijusheng.com
- Country:CHINA
- ProdList:28172
- Advantage:58
-
Supplier:
- Tel:+1-631-485-4226
- Email:inquiry@bocsci.com
- Country:United States
- ProdList:19552
- Advantage:58
-
Supplier:
- Tel:18502101150
- Email:ft-sales@nature-standard.com
- Country:CHINA
- ProdList:1923
- Advantage:58
-
Supplier:
- Tel:+86-27-8439 4403<br/>18971486879
- Email:sales@chemnorm.com
- Country:CHINA
- ProdList:2935
- Advantage:58
-
Supplier:
- Tel:+1-781-999-5354<br/>+1-00000000000
- Email:marketing@targetmol.com
- Country:United States
- ProdList:32222
- Advantage:58
-
Supplier:
- Tel: +8613367258412
- Email:ada@ipurechemical.com
- Country:China
- ProdList:10244
- Advantage:58
107668-79-1, Bulleyaconitine ARelated Search:
- 4'-Hydroxynonanophenone N-OCTADECANOPHENONE Bulleyaconitine A p-hexadecylphenol 1-PHENYLOCTADECANE 4-tetradecylphenol 4-n-Octadecylphenol CYCLOHEXYL 4-METHOXYPHENYL KETONE TETRAHYDROIONYL ACETATE ISO-METHYL TETRAHYDROIONYL ACETATE N-HEXADECANOPHENONE N-TETRADECANOPHENONE CYCLOPENTYL 4-METHOXYPHENYL KETONE CIS-(2-AMINO-CYCLOPENTYL)-METHANOL N-HEPTADECANOPHENONE N-TRIDECANOPHENONE 3-HYDROXY-2-METHYL-1-PHENYL-HEXAN-1-ONE 1-(4-HYDROXYPHENYL)DODECAN-1-ONE
- reference standards from Chinese medicinal herbs (TCM).
- phytochemical
- pharmaceutical intermediate
- chemical reagent
- Natural Plant Extract
- Inhibitors
- standardized herbal extract
- 生物碱类
- 抑制剂
- 高端化学
- 试剂
- 日用化学品
- 原药中间体
- 化工原料
- 标准品 -中药标准品
- 原料药
- 标准品,对照品
- 医药原料药 科研原料
- 标准品-中药标准品
- 医药原料
- 中药标准品
- 植提标准品
- 对照品
- 小分子抑制剂
- 植物提取物
- 小分子抑制剂,天然产物
- 医药原料药
- 分析标准品
- 对照品,标准品
- 标准品
- 中药对照品
- 中草药成分
- C35H49NO9
- 79572-91-9
- 草乌甲素,10 MM DMSO 溶液
- 草乌甲素A
- 草乌甲素(对照品)
- 乌头碱A
- 来源于草乌
- 大头乌头碱甲
- 草乌甲素, 来源于草乌
- BULLEYACONITINE A 草乌甲素
- 草乌甲素 20MG
- 草乌甲素(标准品)
- 草乌甲素
- 107668-79-1
- Bulleyaconitine A, 10 mM in DMSO
- Bulleyaconitine A-RM
- (-)-Syringaresinol 4-O-β-D-glucopyranosi
- Bulleyaconitine A USP/EP/BP
- Methanone, [(1α,6α,14α,16β)-8-(acetyloxy)-20-ethyl-13-hydroxy-1,6,16-trimethoxy-4-(methoxymethyl) aconitan-14-yl](4-methoxyphenyl)-
- crassicauline A(bulleyaconitine
- Bulleyaconitine A, 98%, from Aconitum kusnezoffii Rchb.
- ((1-α,6-α,14-α,16-β)-8-(acetyloxy)-20-ethyl-13-hydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl)(4-methoxyphenyl)-methanone
- Bulleyaconitine
- Methanone, [(1a,6a,14a,16b)-8-(acetyloxy)-20-ethyl-13-hydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl](4-methoxyphenyl)-
- Aconitane,Methanone deriv
- BULLEYACONITINE A(RG)